Zentel 400 mg Tablets
PDF Leaflet Revision Date: 26 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of single or mixed intestinal parasites.
Dosage (summary)
400 mg as a single dose for adults and children over 2 years.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; unknown safety in breastfeeding.
Key Drug Interactions
- Praziquantel increases plasma levels
- Ritonavir, phenytoin, carbamazepine, phenobarbital may reduce plasma concentrations
Contraindications
- Pregnancy
- Hypersensitivity to albendazole
Common side effects
- Headache
- Dizziness
- Gastrointestinal symptoms
- Rash
Counselling Points
- Avoid during early pregnancy
- Monitor for efficacy with interacting drugs
- Caution advised for skilled tasks due to dizziness
Serious warnings
- Leucopenia with prolonged use
- Potential neurological symptoms post-treatment
Important Disclaimer
The Zentel 400 mg Tablets professional information leaflet below is the property of Glaxosmithkline South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
